In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...